A study evaluates the feasibility and clinical utility of integrating routine, electronic patient-reported outcome screening into a dedicated thyroid cancer survivorship clinic to monitor long-term ...

Emergency presentation (EP) for cancer diagnosis is common among older U.S. adults and predicts persistently elevated mortality, according to a study published ...

Researchers investigated inotuzumab ozogamicin for children with CD22-positive, very high-risk first B-cell acute lymphoblastic leukemia relapse.

Investigators evaluated the relationship between overall survival and discontinuing immune checkpoint inhibitor therapy due to immunological toxicity in patients with metastatic melanoma.

Remote patient-reported outcome (PRO) monitoring may improve cancer care for underserved patients, according to a study recently published in JCO Oncology Practice. Allison M. Deal, from the ...

A new model, based on factors identified via machine learning, predicts overall survival at 1, 3, and 5 years after nephrectomy for nonmetastatic renal cell carcinoma (RCC). A separate study suggests ...

A systematic review and meta-analysis compared clinical and patient-reported outcomes between subcapsular and total orchiectomy in patients with advanced prostate cancer.

Researchers investigate the potential relationship between digital health engagement and psychological distress among US adults using cross-sectional survey data.

Researchers assessed whether patient-level socioecological comorbidities delay curative-intent colorectal cancer treatment.

A secondary analysis of the DIPLOMA-2 trial evaluates differences in early physical activity and physiologic stress recovery between patients undergoing minimally invasive vs open ...

The index provides additional prognostic separation beyond Memorial Sloan Kettering Cancer Center risk categories and established clinical factors.

Nonrelapse mortality dropped to a single death across 94 transplants, which the authors linked to consistent prophylaxis and supportive care rather than to any new therapy.